Stock Groups

J&J settles with West Virginia on opioid litigation for $99 million -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid

By Dietrich Knauth

(Reuters) -Johnson & Johnson said on Monday it had agreed to pay $99 million to settle opioid-related claims by the state of West Virginia and its subdivisions.

This settlement ends the ongoing Kanawha County Circuit Court trial against Teva Pharmaceuticals Industries Ltd. that started earlier in this month. Teva Pharmaceuticals industries Ltd. in West Virginia remains under investigation. AbbVie Inc (NYSE)’s Allergan

J&J (NYSE:) did not admit liability or wrongdoing in the settlement, the company said.

[ad_2]